Related Experiment Video
Updated: Oct 8, 2025

07:40
Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders
Published on: April 14, 2017
20.9K
Modeling human neurodevelopmental diseases with brain organoids.
Xiaoxiang Lu1, Jiajie Yang1, Yangfei Xiang2
1School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Cell Regeneration (London, England)
|January 4, 2022
Summary
Human pluripotent stem cells (hPSCs)-derived brain organoids offer a novel way to study neurodevelopmental diseases. These models help uncover disease mechanisms and advance therapeutic strategies for brain disorders.
Area of Science:
- Neuroscience
- Developmental Biology
- Stem Cell Biology
Background:
- Investigating human neurodevelopmental diseases is challenging due to brain complexity and limited accessibility.
- Human pluripotent stem cells (hPSCs)-derived brain organoids mimic human brain development and function.
- Brain organoids provide a unique platform for studying disease pathogenesis.
Purpose of the Study:
- To review the latest advancements in modeling human neurodevelopmental disorders using brain organoids.
- To highlight the utility of brain organoids in understanding disease mechanisms.
- To discuss the integration of gene editing technologies with brain organoids for disease modeling.
Main Methods:
- Utilizing human pluripotent stem cells (hPSCs) to generate brain organoids.
- Employing advanced imaging and molecular techniques to characterize organoid development.
- Integrating gene editing tools (e.g., CRISPR-Cas9) for disease modeling.
Main Results:
- Brain organoids successfully recapitulate key features of human brain development.
- Disease-associated phenotypes and underlying mechanisms for neurodevelopmental disorders have been identified using organoids.
- The combination of brain organoids and gene editing enhances the accuracy of human disease modeling.
Conclusions:
- Brain organoids are powerful tools for studying the etiology of human neurodevelopmental diseases.
- This approach facilitates the identification of novel therapeutic targets and strategies.
- Future research will likely leverage organoid technology for personalized medicine in neurodevelopmental disorders.

